At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; Pharmacia Corporation
- Class Antineoplastics
- Mechanism of Action Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 05 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation
- 18 Nov 1998 New profile
- 18 Nov 1998 Preclinical development for Cancer in Italy (Unknown route)